YU76601A - Novel crystalline forms of a macrolide antibiotic - Google Patents

Novel crystalline forms of a macrolide antibiotic

Info

Publication number
YU76601A
YU76601A YU76601A YUP76601A YU76601A YU 76601 A YU76601 A YU 76601A YU 76601 A YU76601 A YU 76601A YU P76601 A YUP76601 A YU P76601A YU 76601 A YU76601 A YU 76601A
Authority
YU
Yugoslavia
Prior art keywords
crystalline forms
novel crystalline
macrolide antibiotic
forms
macrolide
Prior art date
Application number
YU76601A
Other languages
Serbo-Croatian (sh)
Inventor
Robert John Rafka
Douglas John Meldrum Allen
Colman Brendan Ragan
Barry James Morton
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU76601A publication Critical patent/YU76601A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Opisani su novi kristalni oblici jedinjenja formule (I). Opisani su takodje i farmaceutski preparati koji sadrže ove oblike i postupci za njihovo dobijanje i upotrebu.New crystalline forms of the compounds of formula (I) are described. Also described are pharmaceutical compositions containing these forms and methods for their preparation and use.

YU76601A 1999-05-18 2000-04-14 Novel crystalline forms of a macrolide antibiotic YU76601A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13464499P 1999-05-18 1999-05-18

Publications (1)

Publication Number Publication Date
YU76601A true YU76601A (en) 2004-09-03

Family

ID=22464300

Family Applications (1)

Application Number Title Priority Date Filing Date
YU76601A YU76601A (en) 1999-05-18 2000-04-14 Novel crystalline forms of a macrolide antibiotic

Country Status (43)

Country Link
US (1) US6583274B1 (en)
EP (1) EP1189912B1 (en)
JP (1) JP3897983B2 (en)
KR (1) KR100474229B1 (en)
CN (1) CN1203084C (en)
AP (1) AP2001002325A0 (en)
AR (1) AR020030A1 (en)
AT (1) ATE392427T1 (en)
AU (1) AU772283B2 (en)
BG (1) BG106150A (en)
BR (1) BR0011300A (en)
CA (1) CA2372206C (en)
CZ (1) CZ20014120A3 (en)
DE (1) DE60038610T2 (en)
DK (1) DK1189912T3 (en)
DZ (1) DZ3043A1 (en)
EA (1) EA003417B1 (en)
ES (1) ES2302689T3 (en)
GT (1) GT200000072A (en)
HK (1) HK1045521B (en)
HN (1) HN2000000056A (en)
HR (1) HRP20010849A2 (en)
HU (1) HUP0201341A3 (en)
IL (2) IL145946A0 (en)
IS (1) IS6127A (en)
MA (1) MA26735A1 (en)
MX (1) MXPA01011914A (en)
MY (1) MY133397A (en)
NO (1) NO320195B1 (en)
NZ (1) NZ514765A (en)
OA (1) OA11876A (en)
PA (1) PA8495001A1 (en)
PE (1) PE20010151A1 (en)
PL (1) PL353316A1 (en)
PT (1) PT1189912E (en)
SK (1) SK16472001A3 (en)
TN (1) TNSN00103A1 (en)
TW (1) TWI225066B (en)
UA (1) UA67842C2 (en)
UY (1) UY26144A1 (en)
WO (1) WO2000069874A1 (en)
YU (1) YU76601A (en)
ZA (1) ZA200109420B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
NZ518665A (en) * 2000-01-27 2005-02-25 Pfizer Prod Inc Azalide antibiotic compositions
EP1383780A1 (en) * 2001-04-27 2004-01-28 Pfizer Products Inc. Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
EP1435359A1 (en) * 2002-12-31 2004-07-07 Alembic Limited A process for the purification of roxithromycin
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
KR20110099791A (en) * 2009-01-30 2011-09-08 글락소 그룹 리미티드 Anti-inflammatory macrolide
EP2402355A1 (en) * 2010-07-01 2012-01-04 Novartis AG Crystalline anhydrous forms II and III of Tulathromycin
EP2736915A1 (en) 2011-07-27 2014-06-04 Farma GRS, d.o.o. New crystalline forms of tulathromycin
CN106008622A (en) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 Tulathromycin new crystal form and preparation thereof
CN109942652B (en) * 2017-12-21 2022-04-26 洛阳惠中兽药有限公司 Crystal form I of lecithromycin, preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2066324C1 (en) * 1987-07-09 1996-09-10 Пфайзер Инк. Crystalline azithromycin dehydrate, and process for preparation thereof
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
HN1998000086A (en) * 1997-06-11 1999-03-08 Pfizer Prod Inc DERIVATIVES OF 9 - DESOFO - 9 AZA - 9A - HOMOERITROMICINA A - C - 4 SUBSTITUTED.

Also Published As

Publication number Publication date
MXPA01011914A (en) 2002-05-06
TWI225066B (en) 2004-12-11
NZ514765A (en) 2004-05-28
GT200000072A (en) 2001-11-08
OA11876A (en) 2006-03-27
EA200100984A1 (en) 2002-06-27
DE60038610T2 (en) 2009-06-25
KR20020007415A (en) 2002-01-26
BG106150A (en) 2002-05-31
IL145946A0 (en) 2002-07-25
JP3897983B2 (en) 2007-03-28
AU772283B2 (en) 2004-04-22
CA2372206C (en) 2006-01-10
HN2000000056A (en) 2001-02-02
AP2001002325A0 (en) 2001-12-31
NO20015598L (en) 2002-01-08
DE60038610D1 (en) 2008-05-29
DK1189912T3 (en) 2008-06-30
JP2002544283A (en) 2002-12-24
UA67842C2 (en) 2004-07-15
SK16472001A3 (en) 2003-02-04
IS6127A (en) 2001-10-26
CZ20014120A3 (en) 2003-01-15
CN1203084C (en) 2005-05-25
HUP0201341A2 (en) 2002-08-28
IL145946A (en) 2007-06-17
EP1189912A1 (en) 2002-03-27
HRP20010849A2 (en) 2003-04-30
ES2302689T3 (en) 2008-08-01
PE20010151A1 (en) 2001-02-08
ZA200109420B (en) 2002-11-15
CA2372206A1 (en) 2000-11-23
CN1351607A (en) 2002-05-29
WO2000069874A1 (en) 2000-11-23
DZ3043A1 (en) 2004-03-27
PT1189912E (en) 2008-05-16
BR0011300A (en) 2002-02-26
PA8495001A1 (en) 2002-02-21
US6583274B1 (en) 2003-06-24
HK1045521A1 (en) 2002-11-29
TNSN00103A1 (en) 2005-11-10
MA26735A1 (en) 2004-12-20
KR100474229B1 (en) 2005-03-08
MY133397A (en) 2007-11-30
ATE392427T1 (en) 2008-05-15
EP1189912B1 (en) 2008-04-16
UY26144A1 (en) 2000-12-29
HK1045521B (en) 2005-12-09
HUP0201341A3 (en) 2003-03-28
NO320195B1 (en) 2005-11-14
AR020030A1 (en) 2002-03-27
NO20015598D0 (en) 2001-11-16
AU3572900A (en) 2000-12-05
PL353316A1 (en) 2003-11-17
EA003417B1 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
HUP0302435A2 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and pharmaceutical compositions containing them
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
ME00017B (en) Camptothecin derivatives having antitumor activity
EA199900937A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING VORIKONAZOL
BRPI0406801B8 (en) thieno-pyrimidinedione derivatives and their use in the modulation of autoimmune diseases
IL173810A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
SE0302192D0 (en) Novel compounds
EA199901016A1 (en) 9-OXYM DERIVATIVES OF ERYTHROMYCIN
MX9300278A (en) ARILALCOXIFENOXI-IMIDAZOLINE COMPOUNDS.
HUP0300370A2 (en) 2-hydroxy-mutilin carbamate derivatives of antibacterial effect process for preparation and pharmaceutical compositions containing them
YU76601A (en) Novel crystalline forms of a macrolide antibiotic
DE60301339D1 (en) PYRAZOLOPYRIMIDINE AND PYRAZOLOTRIAZINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF
NO20020282L (en) New diphenyl-piperidine derivative
BR0314363A (en) 2,4-substituted indols and their use as 5-ht6 modulators
IL173895A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
IL173809A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
AP9801377A0 (en) Tricyclic erythromycin derivatives.
SE9902551D0 (en) Novel compounds
DE69330601T2 (en) SEROTON INERGIC ERGOLIN DERIVATIVES
EA200600022A1 (en) APPLICATION OF DERIVATIVE BICYCLO [2.2.1] HEPTANA TO PREPARE NEUROPROTECTIVE PHARMACEUTICAL COMPOSITIONS
AP9801235A0 (en) Erythromycin derivatives.
DE60130009D1 (en) macrolides
DE60119383D1 (en) FARNESYL TRANSFERASE-INHIBITING 4-HETEROCYCLYLCHINOLIN AND CHINAZOLINE DERIVATIVES
DE69418715T2 (en) ERYTHROMYCINE DERIVATIVES